Literature DB >> 20190780

Deal watch: Novartis licenses GenVec's hearing loss programme.

.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20190780     DOI： 10.1038/nrd3126

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

Review 1.  Quo vadis, hair cell regeneration?

Authors:  John V Brigande; Stefan Heller
Journal:  Nat Neurosci       Date:  2009-05-26       Impact factor: 24.884
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.